ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 23.20 billion. The enterprise value is 36.13 billion.

Market Cap	23.20B
Enterprise Value	36.13B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has decreased by -2.01% in one year.

Current Share Class	n/a
Shares Outstanding	10.87M
Shares Change (YoY)	-2.01%
Shares Change (QoQ)	-27.03%
Owned by Insiders (%)	36.07%
Owned by Institutions (%)	4.95%
Float	6.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
PB Ratio	0.54
P/TBV Ratio	0.54
P/FCF Ratio	6.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.11, with an EV/FCF ratio of 10.12.

EV / Earnings	-11.25
EV / Sales	1.03
EV / EBITDA	62.11
EV / EBIT	n/a
EV / FCF	10.12

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.38.

Current Ratio	2.07
Quick Ratio	0.17
Debt / Equity	0.38
Debt / EBITDA	28.52
Debt / FCF	4.65
Interest Coverage	-0.96

Financial Efficiency

Return on equity (ROE) is -7.21% and return on invested capital (ROIC) is -2.37%.

Return on Equity (ROE)	-7.21%
Return on Assets (ROA)	-2.00%
Return on Capital (ROIC)	-2.37%
Revenue Per Employee	437.97M
Profits Per Employee	-40.15M
Employee Count	80
Asset Turnover	0.48
Inventory Turnover	1.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.17% in the last 52 weeks. The beta is 0.90, so ENBIO's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-37.17%
50-Day Moving Average	2,144.50
200-Day Moving Average	2,494.63
Relative Strength Index (RSI)	56.75
Average Volume (20 Days)	11,384

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 35.04 billion and -3.21 billion in losses. Loss per share was -296.89.

Revenue	35.04B
Gross Profit	7.97B
Operating Income	-2.36B
Pretax Income	-4.07B
Net Income	-3.21B
EBITDA	581.72M
EBIT	-2.36B
Loss Per Share	-296.89

Full Income Statement

Balance Sheet

The company has 3.66 billion in cash and 16.59 billion in debt, giving a net cash position of -12.93 billion or -1,189.84 per share.

Cash & Cash Equivalents	3.66B
Total Debt	16.59B
Net Cash	-12.93B
Net Cash Per Share	-1,189.84
Equity (Book Value)	43.21B
Book Value Per Share	3,976.29
Working Capital	22.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.56 billion and capital expenditures -6.99 billion, giving a free cash flow of 3.57 billion.

Operating Cash Flow	10.56B
Capital Expenditures	-6.99B
Free Cash Flow	3.57B
FCF Per Share	328.52

Full Cash Flow Statement

Margins

Gross margin is 22.76%, with operating and profit margins of -6.73% and -9.17%.

Gross Margin	22.76%
Operating Margin	-6.73%
Pretax Margin	-11.63%
Profit Margin	-9.17%
EBITDA Margin	1.66%
EBIT Margin	-6.73%
FCF Margin	10.19%

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.01%
Shareholder Yield	2.01%
Earnings Yield	-13.91%
FCF Yield	15.39%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.38
Piotroski F-Score	n/a